Industry Symposia: Astellas - Looking Beyond the Prescription: A Holistic Phenotyping Approach to Optimising OAB Treatment Response

ICS Members Only
Join ICS Sign in
{{CC.VideoPaywallHeaderText}}
{{CC.VideoPaywalButtonText}} Sign in Sign in
Restricted Video
Sign in Join Now
Industry Symposia: Astellas - Looking Beyond the Prescription: A Holistic Phenotyping Approach to Optimising OAB Treatment Response

ICS Members Only Restricted Video

Satellite Symposium
Thursday 8th October 2026
12:45 - 13:30
Parallel Hall 3
0.4 Brussels / 0.5 Paris
Capacity: 356
Lunch provided
Speakers
M

Marcus John Drake
Speaker

P

Philip Edward Van Kerrebroeck
Speaker

E

Elise Jaques Billings De
Speaker

Professional interest
Urology Urogynaecology and Female & Functional Urology Pure and Applied Science
22/10/2026 11:03:31
Time (DST)SessionFaculty
12:45‑12:47
(2 min)		Welcome and Introduction
12:47‑12:53
(6 min)		The Treatment Response Challenge in OAB
Objective: Explore the role of pharmacotherapy in OAB management and introduce why understanding the factors influencing treatment response is essential for optimising patient outcomes
12:53‑13:03
(10 min)		Why Phenotyping Matters: Understanding What Drives Treatment Response
Objective: Introduce a practical phenotype-driven approach to understanding OAB heterogeneity and optimising treatment response through more personalised patient assessment
13:03‑13:23
(20 min)		Optimising Treatment Response: A Phenotype-Driven Case Discussion
Objective: Apply a phenotype-driven, holistic approach to a challenging patient case with persistent OAB symptoms despite pharmacological therapy and explore how identifying previously unrecognised contributors to symptoms can help optimise treatment response and guide appropriate treatment decisions.
13:23‑13:28
(5 min)		Ask the Faculty Q&AAll faculty
13:28‑13:30
(2 min)		Meeting Summary and Close

Comments

Chat

Content Visitors (staff only)